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Abstract 
Review on t(3;5)(q21;q31), with data on clinics, 
and the genes implicated. 
Clinics and pathology 
Disease 
Acute myeloid leukemia (AML), myelodysplastic 
syndrome (MDS), and myeloproliferative disorder 
(MPD) 
Note 
26 cases of t(3;5)(q21;q31) in myeloid malignancy 
are available (Oshimura et al., 1976; Dewald, 1984; 
Bitter et al., 1985; Testa et al., 1985; Werner-Favre 
et al., 1985; Pi and Kalousek, 1986; Smadja et al., 
1986; McCarthy et al., 1987; Sharp et al., 1987; 
Akiyoshi et al., 1991; Katz et al., 1992; Solé et al., 
1992; Secker-Walker et al., 1995; Wong and 
Kwong, 1995; Groupe Français de Cytogénétique 
Hématologique, 1996; Dong et al., 1998; Mazzella 
et al., 1998; Misawa et al., 1998; Green et al., 1999; 
Berger et al., 2006; Lugthart et al., 2010). We have 
excluded from this review a case of acute 
lymphoblastic leukemia (Chen et al., 1992). 
Phenotype/cell stem origin 
There was 5 M6-AMLs, 2 M4-AMLs, 10 M2-
AMLs, and 6 AMLs not otherwise specified (AML-
NOS), 1 myeloid metaplasia with myelofibrosis 
(MMM) in acute phase, another myeloproliferative  
syndrome not otherwise specified, and a refractory 
anemia with excess of blasts in transformation 
(RAEB-t).  
There was no reference with a previous toxic 
exposure. 
Epidemiology 
Median age was 36-38 years (range 3-85, with two 
pediatric cases aged 3); sex ratio was 11M/14F. 
Prognosis 
Data on survival is very scarce (patients alive at 3 
months, 21 months, 29 months, and 30 months; and 
patients dead at 7 and 9 months). 
Cytogenetics 
Cytogenetics morphological 
The t(3;5)(q21;q31) was the sole anomaly in 20 of 
25 cases.  
Complex karyoptypes were present in 3 cases. A 
del(5q)/-5 was found in one case, a del(7q)/-7 was 
found in two cases, and a +8 in two cases. 
Genes involved and 
proteins 
Note 
The genes involved in this translocation remain 
unknown. 
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t(3;5)(q21;q31). G- banding (left) - top three: Courtesy Christine Perot; bottom: Courtesy Francine Mugneret; and R- banding 
(right) - top three: Courtesy Christine Perot; bottom three: Courtesy Francine Mugneret. 
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